Adrián LLerena is the Director of INUBE Extremadura Biosanitary Research Institute and the Clinical Research Center in the University Hospital, Badajoz Spain. He is also Professor of Pharmacology and Clinical Pharmacology in the Medical School of the University of Extremadura Spain and it was part time in the University of Beira Interior, Portugal, between 1989 to 1993 did his post doc at Karolinska Institute Sweden focusing on Clinical Pharmacogenetics. He has also been Visiting Professor in different Universities in USA such as University of California at Los Angeles 2004 Mount Sinai Medical School at NY 2005 and Miller Medical School at Miami 2006, UNC North Caroline and in Latin America such as UNAM in Mexico San Marcos in Peru Chile Brazil etc. He is also coordinating the RIBEF Ibero-American network of Pharmacogenetics since 2006. He served in different Scientific societies as Ibero-American Society of Pharmacogenomics. Former Vice-president of the Spanish Society of Clinicial Pharmacology and President of the Spanish Society for Pharmacogenetics and Pharmacogenomics (2019-23). Coordinator of the IMPaCT WP05-BioFRAM-MedeA Pharmacogenetics Implementation Projects in Spanish Health System.

Collet Dandara is a Professor of Human Genetics and Principal Investigator of the Pharmacogenomics and Drug Metabolism Research Group at the University of Cape Town. From the start of his career, his research focused on pharmacogenetics and later pharmacogenomics, characterising African genomes to identify genomic factors influencing differential drug responses. His work has established a foundation for understanding genetic variants of pharmacogenomic importance in African populations, leading to novel discoveries and mechanistic insights into these variants and their networks. The group’s research has also explored the pharmacogenomics of widely used herbal medicines. Professor Dandara was nominated Vice-Chair of the African Consortium of Pharmacogenomics (APC) in 2018, is a member of the African Society of Human Genetics (AfSHG), serves on the International Scientific Advisory Committee for the Human Variome Project (HVP), and is involved in the Global Genomic Medicine Collaboration (G2MC) and the Global Pharmacogenomics Network. He has authored over 140 publications, with an H-index of 26 and i10-index of 60, and serves on several editorial boards. He received the TWAS Young Affiliate Award in 2012 and sits on the TWAS Young Affiliate Network Executive. A finalist in the 2014 NSTF Awards for Human Capacity Development, he has supervised numerous MSc and PhD students and serves on multiple University of Cape Town committees, including the Faculty of Health Sciences Transformation Committee, and on the SAYAS selection committee.

Sophie Stocker is an Associate Professor in the Sydney Pharmacy School. She is also an Honorary Senior Hospital Scientist in the Department of Clinical Pharmacology and Toxicology at St Vincent’s Hospital, Sydney; an Adjunct Senior Lecturer of the St Vincent’s Clinical School, University of New South Wales; and an Honorary Scientist at the Garvan Medical Research Institute. Her research program involves clinical and experimental pharmacology, ethnopharmacology, pharmacogenomics, pharmacometrics and qualitative research on the impact of intrinsic and extrinsic factors on drug disposition, efficacy and safety. Her research focuses on understanding variability in response to medicines and how this can be managed to optimise patient care.

Kaisa Litonius, MD, MA, is a PhD student at the University of Helsinki and a physician specializing in clinical pharmacology at HUS Helsinki University Hospital. She earned her medical degree in 2021 and a Master of Arts degree in 2015, both from the University of Helsinki. Her doctoral research explores the integration of pharmacogenetic panel testing into healthcare, aiming to enhance personalized medicine in everyday clinical practice. Her key research interests include the real-world impact of pharmacogenetics, drawing on large-scale registry and biobank data.

Dr Stefanie Lip is a Clinical Senior Lecturer at the University of Glasgow and an Honorary Consultant in General Internal Medicine & Clinical Pharmacology and Therapeutics at the Queen Elizabeth University Hospital (NHS Greater Glasgow & Clyde). Her research focuses on pharmacogenomics and hypertension.